Vaso (VASO) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Vaso Corporation  (VASO)


Vaso's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Vaso's ROA in the second quarter of 2026?
Vaso Corporation achieved a return on average assets (ROA) of 2.97 % in its second quarter of 2026, this is above VASO's average return on assets of 2.56%.
Vaso Corporation assets over the 12 months ending in its second quarter of 2026 are valued at $84 million

ROA has improved compared to 2.13% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 182 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 1810, from total ROA ranking in the first quarter of 2026 at 2184.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 7.09 % 6.51 % 30.21 % 21.11 % 17.35 %
Y / Y Net Income Change - - -47.44 % - -
Net Income (TTM) in million 2 2 2 3 0
Return On Assets (TTM) 2.97 % 2.13 % 1.93 % 3.38 % -0.42 %
VASO's Total Ranking # 1810 # 2184 # 1555 # 2629 # 2008
Total Assets (TTM) in million 86 83 83 84 80
Seq. Total Assets Change 3.52 % 0.33 % -2.09 % 5.31 % 2.96 %
Seq. Net Income Change - - -33.96 % - -

VASO's 5 Years Annual ROA >> Back to VASO Management Effectiveness >> Compare VASO ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 54
Sector # 183
Overall # 1603

Return On Assets Statistics
High Average Low
46.32 %
2.56 %
-25.76 %
(Dec 31 2011)   (Mar 31 2014)





Financial Statements
Vaso's Assets $ 86 million VASO's Balance sheet
Vaso's Income $ 1 million Quarterly VASO's Income Statement
VASO's Income by Division See VASO's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 26.91 % -11.95 % 29.43 % 30.54 % 3.94 %
Total Assets in million 99 78 88 68 52
Y / Y Net Income Change 64.98 % -80.21 % -59.53 % - -
Net Income in million 2 1 5 12 0
Annual Return On Assets 1.59 % 1.22 % 5.43 % 17.37 % 0 %

VASO's 5 Years Annual ROA >> Back to VASO Management Effectiveness >> Compare VASO ROA to its Competitors



Comment on VASO's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 1.59 % compared to prior year, due to annual net income growth of 64.98 % to $1.57 million, while value of Vaso's overall assets grew just by 26.91 % to $98.85 million, compared to $98.85 a year before.


More Return On Assets Ratios
VASO's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
VASO's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for VASO's Competitors
Subscribers only: Roa for Vaso's Suppliers
Subscribers only: Return On Assets for VASO's Customers

You may also want to know
VASO's Roi VASO's Inventory Turnover Ratio VASO's Growth Rates VASO's Dividend Comparisons
VASO's Profitability Ratios VASO's Asset Turnover Ratio VASO's Dividend Growth
VASO's Roe VASO's Valuation Ratios VASO's Financial Strength Ratios VASO's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Pediatrix Medical Group Inc   8.09 %
Veracyte Inc   8.04 %
Stryker Corp  7.89 %
Lifevantage Corp  7.87 %
Embecta Corp   7.82 %
Beone Medicines Ltd   7.82 %
Viemed Healthcare Inc   7.49 %
Edwards Lifesciences Corporation  7.41 %
Ani Pharmaceuticals Inc  7.40 %
Addus Homecare Corp  7.32 %
Livanova Plc  7.31 %
Pacific Health Care Organization Inc  7.17 %
Nature s Sunshine Products inc   7.14 %
Bio techne Corp  7.12 %
Concentra Group Holdings Parent Inc   7.09 %
Phibro Animal Health Corporation  7.01 %
Ensign Group Inc  6.88 %
Royalty Pharma Plc  6.87 %
Davita Inc   6.77 %
Quest Diagnostics Inc  6.74 %
Align Technology inc   6.56 %
Corcept Therapeutics Inc  6.45 %
Brightspring Health Services Inc   5.93 %
Amneal Pharmaceuticals Inc   5.90 %
Siga Technologies Inc  5.73 %
Medtronic Plc  5.71 %
Labcorp Holdings Inc   5.40 %
Merit Medical Systems Inc  5.34 %
Sotera Health Company  5.03 %
Vericel Corporation  5.02 %

Date modified: 2026-08-17T07:34:22+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.